Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,990
Closed -$265K 2068
2026
Q1
$265K Buy
+40,990
New +$320K ﹤0.01% 1336
2023
Q3
Sell
-31,060
Closed -$485K 2141
2023
Q2
$485K Buy
+31,060
New +$666K ﹤0.01% 1372
2022
Q4
Sell
-6,441
Closed -$177K 2129
2022
Q3
$177K Buy
+6,441
New +$226K ﹤0.01% 1667
2022
Q2
Sell
-17,074
Closed -$1.33M 2446
2022
Q1
$1.33M Buy
+17,074
New +$1.07M 0.02% 983
2021
Q4
Sell
-2,521
Closed -$285K 2591
2021
Q3
$285K Sell
2,521
-4,068
-62% -$558K ﹤0.01% 1633
2021
Q2
$1.19M Buy
6,589
+1,811
+38% +$318K 0.01% 912
2021
Q1
$1.09M Buy
+4,778
New +$1.12M 0.02% 870
2020
Q3
Sell
-4,312
Closed -$307K 2229
2020
Q2
$307K Buy
+4,312
New +$348K 0.01% 1308
2020
Q1
Sell
-1,733
Closed -$297K 1632
2019
Q4
$297K Buy
+1,733
New +$358K 0.01% 1151

Other funds holding TLRY

Michael Gelband's TLRY Position: Q2 2026 in Review

Michael Gelband sold out of Tilray (TLRY) in Q2 2026, closing a stake of 40,990 shares — an estimated $265K sold.

Michael Gelband first reported a position in TLRY in Q4 2019 and held it in 9 quarters. The position peaked at $1.33M in Q1 2022. 234 funds tracked by Wall St. Rank hold TLRY as of Q2 2026.

  • Michael Gelband reported no remaining Tilray position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 40,990 Tilray shares in Q2 2026, an estimated $265K.
  • Michael Gelband first reported a position in Tilray in Q4 2019 and held it in 9 quarters.
  • Michael Gelband's Tilray position peaked at $1.33M in Q1 2022.
  • 234 funds tracked by Wall St. Rank held Tilray as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.